---
category: news
title: "Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart"
excerpt: "Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the companyâ€™s new Ultreon Software."
publishedDateTime: 2021-08-03T13:04:00Z
originalUrl: "https://apnews.com/press-release/pr-newswire/technology-business-health-artificial-intelligence-a3106af70cfadf9b853ccf8f75da1088"
webUrl: "https://apnews.com/press-release/pr-newswire/technology-business-health-artificial-intelligence-a3106af70cfadf9b853ccf8f75da1088"
type: article
quality: 19
heat: -1
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "FDA OKs Abbott's OCT Imaging Platform With Artificial Intelligence - Quick Facts"
    excerpt: "Abbott Laboratories (ABT) announced Tuesday that it has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software."
    publishedDateTime: 2021-08-03T13:47:00Z
    webUrl: "https://www.nasdaq.com/articles/fda-oks-abbotts-oct-imaging-platform-with-artificial-intelligence-quick-facts-2021-08-03"
    type: article
    provider:
      name: Nasdaq
      domain: nasdaq.com
    quality: 42
  - title: "Abbott (ABT) Receives FDA Approval for OCT Imaging Platform"
    excerpt: "Abbott Laboratories ABT recently received the FDA go-ahead for its latest optical coherence tomography (OCT) imaging platform, powered by the company's new Ultreon Software. The Ultreon Software is a first-of-its-kind imaging software that combines OCT with artificial intelligence (AI)."
    publishedDateTime: 2021-08-04T14:43:00Z
    webUrl: "https://www.nasdaq.com/articles/abbott-abt-receives-fda-approval-for-oct-imaging-platform-2021-08-04"
    type: article
    provider:
      name: Nasdaq
      domain: nasdaq.com
    quality: 34
  - title: "Abbott Receives FDA Clearance For Imaging Technology Using Artificial Intelligence For Vessels In The Heart"
    excerpt: "This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst"
    publishedDateTime: 2021-08-03T13:03:00Z
    webUrl: "https://www.benzinga.com/news/21/08/22298045/abbott-receives-fda-clearance-for-imaging-technology-using-artificial-intelligence-for-vessels-in-th"
    type: article
    provider:
      name: Benzinga.com
      domain: benzinga.com
    quality: 19
    images:
      - url: "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png"
        width: 1200
        height: 630
        isCached: true
  - title: "Abbott Receives FDA Clearance For Its Imaging Technology Using Artificial Intelligence For Vessels in the Heart"
    excerpt: "Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software."
    publishedDateTime: 2021-08-04T08:12:00Z
    webUrl: "https://www.pharmiweb.com/pwtoday-story/abbott-receives-fda-clearance-for-its-imaging-technology-using-artificial-intelligence-for-vessels-in-the-heart"
    type: article
    provider:
      name: PharmiWeb
      domain: pharmiweb.com
    quality: 19
    images:
      - url: "https://cdn.pharmiweb.com/media/13040/abbott_300x400-1.jpg"
        width: 300
        height: 400
        isCached: true

secured: "uv5/BJ4Cm8tGWpbXWY66DRoTi+LcFUb66AS4hvglHTGo1vDJHqHk7chLFfuOLtrAD+n/6xAq5+SN2exCSYjKNN+o15coKaIQXwY6x8N7U/a938vpqVvqp8bpUI98RydLKov5E17198QBMMXQ/Imec7qIJ4Lcn/0y3DQ88Pjc7wpg7rSh4Wch49qUE8E+/Xzi/lRlfHrAGoOTILEGCdkeIjE33fVj1crj7TERiEbZQDrflROnela7Lngb7sf83mgLe7cBY+dJtVqltiQbKIm52+xuss9Z3zgO/vsIQg9q9fCc8DEvqLMb2NzDJr9yX8g6yXYAOcfNHLlFDlgSqCDkpyXRO4BYJLizJ3ya2KSeKAk=;R7rh4UE90KyRl8Am2RtAIw=="
---

